Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041392 | SCV000065086 | likely pathogenic | Rare genetic deafness | 2012-12-28 | criteria provided, single submitter | clinical testing | The Leu583Pro variant in EYA1 has been identified in two probands with clinical features of Branchio-oto-renal syndrome (BOR), was absent from 85 controls, and segregated with clinical features in one affected family member (Rickard 2000, L MM unpublished data). In addition, this residue is conserved across species, and computational analyses (biochemical amino acid properties, homology, PolyPhen2, SIFT) suggest that the variant may impact the protein. In summary, this variant is likely to be pathogenic. |
Fulgent Genetics, |
RCV000763604 | SCV000894450 | likely pathogenic | Branchiootic syndrome 1; Branchiootorenal syndrome 1; Otofaciocervical syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002243687 | SCV002512907 | likely pathogenic | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23435380, 17637804, 24752894, 31049720, 10991693) |
Yale Center for Mendelian Genomics, |
RCV001849294 | SCV002106630 | likely pathogenic | Focal segmental glomerulosclerosis | 2020-05-03 | no assertion criteria provided | literature only |